NBTX — Nanobiotix S.A.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1760854 ·
Last close
$40.80
Market Cap
$1.98B
52W High
$57.14
52W Low
$28.18
ADV30
90,984
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 67,760,000 | 52,750,000 | 152,243,000 |
| Jun 2025 | — | — | — | — | 45,174,000 | 28,818,000 | 114,126,000 |
| Dec 2024 | — | — | — | — | 67,418,000 | 49,737,000 | 133,121,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-23,961,000
Inventory
—
Receivables
$7,680,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$32,593,000
EBITDA
$-10,489,000
Free Cash Flow
$-7,894,125
Enterprise Value
$2,026,958,848
Total Cash
$52,750,000
Total Debt
$95,319,000
Shares Out
48,495,512
Trailing EPS
$-0.58
Book Value
$-1.65
ROE
—
ROA
-10.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 29,643,000 | -10,818,000 | -23,961,000 | 67,760,000 | 152,243,000 | — | -33,422,000 |
| Dec 2024 | -11,610,000 | -68,392,000 | -68,132,000 | 67,418,000 | 133,121,000 | — | -19,551,000 |
| Dec 2023 | 30,058,000 | -26,778,000 | -39,700,000 | 93,897,000 | 95,741,000 | — | -12,476,000 |
| Dec 2022 | 0 | -46,703,000 | -57,041,000 | 59,769,000 | 86,814,000 | — | -37,103,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.15
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TYRA | Tyra Biosciences, Inc. | $2.00B | $33.59 | — |
| AUPH | Aurinia Pharmaceuticals Inc. | $1.95B | $15.19 | — |
| BHC | Bausch Health Companies Inc. | $2.02B | $5.40 | — |
| HCM | HUTCHMED (China) Ltd | $2.02B | $11.75 | — |
| SION | Sionna Therapeutics, Inc. | $1.94B | $42.88 | — |
News headlines (Yahoo Finance, 1h cache)
NANOBIOTIX Announces Closing of Global Offering
2026-05-26 20:59 · Yahoo
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
2026-05-22 20:15 · Yahoo
Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering
2026-05-21 14:57 · Yahoo
Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
2026-05-21 13:30 · Yahoo
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Uncertainty Surrounding US-Iran Talks
2026-05-21 13:18 · Yahoo
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris
2026-05-21 06:30 · Yahoo
Nanobiotix Announces Launch of Global Follow-On Offering
2026-05-20 22:19 · Yahoo
How Nanobiotix Got Wall Street's Attention By Using Physics To Battle Cancer
2026-05-20 12:00 · Yahoo
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
2026-05-17 14:15 · Yahoo
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
2026-05-04 21:29 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.